Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 168 for query «wockhardt»

8 January, 2018 4:10 AM Buy RIL, Wockhardt, Tata Global, NIIT Tech, Yes Bank, DHFL; sell Bharti Infratel: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Reliance Industries, Wockhardt, Tata Global, NIIT Tech, Yes Bank and DHFL and can sell Bharti Infratel. Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Short selling is intraday; we do not want to carry any positions forward. Bharti Infratel is a short sell just for the intraday 32

20 November, 2017 8:31 AM Buy Divis Laboratories, Raymond: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Since we are buying the largecaps through the indices, there are a lot of midcaps which are offering opportunities. Divis Laboratories is coming out of a bear market and is now notching up gains consistently; that should continue." "It is not just Divis, for example Ajanta Pharma was a buy and that is also doing 30

27 October, 2017 11:00 AM Buy Ajanta Pharma, Wockhardt, UPL, Bajaj Finance: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, Wockhardt, UPL and Bajaj Finance. Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Pharmaceutical appears to be the sector of the day. Hence you need to get long on those stocks from an intraday basis. I think Ajanta Pharma is a buy with a stop loss of Rs 1,200 and target of Rs 1,265. Wockhardt 76

4 September, 2017 7:13 AM Buy Wockhardt; sell Tech Mahindra, Indian Oil Corporation: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Wockhardt and sell Tech Mahindra and Indian Oil Corporation. Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Wockhardt is a buy with a stop loss of Rs 615 and target of Rs 640. Tech Mahindra is a sell with a stop loss of Rs 426 and target of Rs 400." "Indian Oil Corporation (IOC) 21

3 July, 2017 2:05 PM Wockhardt gets US FDA nod for generic eye drops

After a long pause,drug maker Wockhardt on Monday said it got final approval from the US FDA for generic version of Novartis eye drops Patanol 0.1 percent. Patanol genericallyt called as olopatadine hydrochloride ophthalmic solution is used to treat signs and symptoms of seasonal allergic conjunctivitis. To be sure Wockhardt will have to compete against 62

3 July, 2017 2:52 AM Stocks in the news: Infosys, Maruti, Tata Motors, Eicher Motors, Kesoram, Sequent

Infosys | Maruti Suzuki | Tata Motors | Eicher Motors | Mahindra & Mahindra | Atul Auto | Reliance Capital | Kesoram Industries | Dabur India | Ramco Systems | Strides Shasun | Sequent Scientific | Zandu Realty | Vardhman Textiles | SCI | NLC India and Inox are stocks, which are in the news today. -Total sales up 7.6 percent at 1.06 lakh units versus 45

23 June, 2017 3:45 AM Sell Just Dial, NMDC, Wockhardt; buy Aditya Birla Nuvo, HDFC: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one can sell Just Dial, NMDC and Wockhardt and can buy Aditya Birla Nuvo and HDFC. Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Just Dial had a fresh breakdown. That is a sell with a stop loss of Rs 400 and target of Rs 375. NMDC is a sell with a stop loss of Rs 114 and target of Rs 102." "In Wockhardt 27

20 June, 2017 7:44 AM Buy Balkrishna Industries, Dabur India: Mitessh Thakkar

Mitessh Thakkar of mitesshthakkar.com advises buying Balkrishna Industries and Dabur India. Mitessh Thakkar of mitesshthakkar.com told CNBC-TV18, "I have been positive on the metals pack. Tata Steel was a recommendation yesterday. JSW Steel could see some follow-up along with Tata Steel maybe Hindalco. Hindalco is something which I am not very bullish 60

8 June, 2017 8:23 AM Buy Balkrishna Industries, Uflex, PVR: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Balkrishna Industries, Uflex and PVR. Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Balkrishna Industries is a buy with a stop loss of Rs 1,550 and target of Rs 1,700. Uflex is a buy with a stop loss of Rs 395 and target of Rs 420." "PVR is also a buy with a stop loss of Rs 1,400 and target 74

7 May, 2017 12:09 AM `Need to draw up standard guidelines for foreign patients, hospitals & docs'

MUMBAI: Ahmad Mecklai, a nonpractising allopathic doctor, was more than a little surprised to receive a phone call at 3am from an oral cancer patient. The patient, a Kenyan national, had arrived in India a few hours earlier and was told to pay Rs 16 lakh to a Delhi hospital by 8am for his treatment. Distraught by the short deadline and the steep medical 44